Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Hyrich KL, Silman AJ, Watson KD, Symmons DP

ARC Epidemiology Unit, University of Manchester, Oxford Road, Manchester M13 9PT, UK.

Anti-TNFalpha therapy may have associated risks of serious infection, congestive heart failure, malignancy, and multiple sclerosis. The magnitude of these risks is difficult to assess. This article reviews publications on the current knowledge about the safety of these agents.

Published 19 November 2004 in Ann Rheum Dis, 63(12): 1538-43.
Full-text of this article is available online (may require subscription).

© 2004-2008 Rheumatoid Arthritis Research Today. All Rights Reserved.